面向下一代工业生物技术的可持续低成本下游处理:BioResin 与 30-L 稀释重力柱
Enabling Sustainable and Cost-Effective Downstream Processing for the Next Generation of Industrial Biotechnology
文章聚焦工业生物技术扩大规模时下游处理(DSP)占生产成本30–60%的瓶颈,指出传统离子交换(IEX)树脂价格常超每升1000欧元且难降解。文中介绍以10 L BioResin产品装填的30-L稀释重力柱,并讨论纤维素、壳聚糖等生物基替代材料在结合容量、机械强度和CIP化学稳定性上的不足。

30-L Ilution gravity column with 10 L BioResin product (photo courtesy of Medium Well, https://mediumwell-tech.com)
As biomanufacturing expands beyond pharmaceuticals into food, nutrition, and industrial biotechnology, downstream processing (DSP) has emerged as one of the most critical barriers to scale, cost efficiency, and sustainability. DSP is one of the most resource- and cost-intensive stages in biotechnology. As co-author Dr. Stefan Rasche and colleagues at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME emphasize, literature commonly places DSP’s contribution in the range of 30–60% of total production costs (1–3), whereas high-purity products may require substantially higher downstream effort. In precision fermentation and bio-based ingredient manufacturing, DSP often determines overall process viability. Multistep operations such as filtration, precipitation, and chromatography require substantial buffer volumes, high energy input, and costly consumables. Those factors form major economic and environmental bottlenecks for sustainable bioprocessing.
Related:Reimagining mAb Purification Through Continuous Chromatography
Nevertheless, liquid chromatography is the most efficient separation technique that preserves proteins in their native structure and promotes their functionality. Enabling low-cost chromatography procedures opens the door to large-scale production using these techniques not only in the biopharmaceutical field, but also in agriculture, food technology, veterinary medicine, and animal health. That goal is especially critical for high-volume, cost-sensitive sectors such as alternative proteins and functional food ingredients, where DSP costs often outweigh raw material and fermentation costs.
The Limits of Conventional Ion-Exchange Chromatography
Ion-exchange (IEX) chromatography remains the industrial gold standard for separating charged biomolecules, including proteins, peptides, nucleic acids, and metabolites. The method’s scalability, robustness, and separation performance make it indispensable across bioprocessing industries.
However, the resins underpinning modern IEX were developed primarily for high-value biopharmaceutical applications. Such materials are typically based on fossil-derived polymers, rely on petrochemical cross-linkers, and are manufactured using energy-intensive processes. As a result, their costs frequently exceed €1000 per liter, placing them far beyond the economic reach of food and industrial biotechnology applications.
Conventional resins also show limited tolerance toward complex feed streams, high solids, and process variability common to fermentation-derived food proteins. From a sustainability perspective, their non-biodegradable nature and limited end-of-life options also conflict with emerging regulatory and circular-economy goals.
Related:High-Performance Liquid Chromatography Continues To Set the Pace for Biopharmaceutical Analytics
To understand the environmental footprint of conventional IEX media, it is necessary to examine their structural anatomy, which typically comprises three components: a structural base-bead matrix, chemical cross-linkers, and functional surface ligands. Legacy industrial resins rely heavily on synthetic, petroleum-derived aromatics such as polystyrene–divinylbenzene (PS-DVB) or polyacrylamide to manufacture the rigid base beads; another option is cross-linked agarose. The cross-linking agents used to provide physical architecture, such as epichlorohydrin or glutaraldehyde, are derived from hazardous petrochemical chains and generate energy-intensive, volatile organic compound (VOC) waste streams during industrial synthesis. Furthermore, specialized synthetic ligands are often attached using halogenated chemistry. Because fossil-derived polymer backbones resist mechanical and biological degradation, spent resin cannot be returned to a biological carbon cycle. Consequently, large-scale manufacturing facilities are forced to rely on landfilling or high-temperature incineration for end-of-life consumption of spent columns, which generates persistent microplastic liabilities and fossil-derived carbon emissions.
Related:Membrane Chromatography: Helping Downstream Processing To Follow Upstream Innovation
Why Existing Bio-Based Alternatives Fall Short
Research into bio-based or biodegradable IEX materials — including cellulose, dextran, lignocellulosic, and chitosan — has grown significantly due to sustainability mandates. These materials align with European Union (EU) circular-economy priorities and reduce dependency on petrochemical inputs.
Yet despite promising laboratory-scale performance, most bio-based chromatography materials lack efficiency, competitive binding capacity, and sufficient mechanical strength, as well as chemical stability under industrial cleaning protocols, often degrading after only a few reuse cycles and requiring energy-intensive preparation steps. As a result, no fully validated alternative to commercial IEX resins has successfully bridged performance with price and sustainability at scale.
Historically, incremental academic successes with bio-based materials have failed to transfer to commercial facilities due to engineering trade-offs between structural rigidity and surface functionalization. Native polysaccharides such as cellulose and chitosan achieve excellent baseline biocompatibility, lower static binding capacities in low-pressure laboratory settings, and weak mechanical moduli. Under the volumetric flow rates and hydrodynamic pressures that are characteristic of industrial column operations, nonoptimized biomatrices undergo severe physical compression, leading to high back pressure or bed collapse after only a few operational cycles.
Furthermore, conventional bio-based materials exhibit poor chemical stability under industrial sanitation protocols. Standard cleaning-in-place (CIP) regimes require aggressive alkaline/acid flushing (typically 0.1–0.5 N NaOH/HCl) to clear fouled host-cell proteins and prevent bioburden accumulation. Under those conditions, bio-resins suffer rapid structural hydrolysis, loss of ligand, and destruction of binding capacity after only a few operational cycles.
Introducing a New Class of IEX Media
Medium Well’s BioResin IEX medium was engineered to address such performance gaps. Rather than retrofitting academic materials or discounting pharmaceutical resins for food use, the medium was designed from first principles as a cost-effective, biodegradable, high-performance IEX resin to meet the unique economics and sustainability requirements of large-scale industrial and food applications.
The BioResin product circumvents the structural vulnerabilities of alternatives through a proprietary green-chemistry architecture. The structural framework is built upon a highly cross-linked backbone using low-cost, food-grade components and plant-based byproducts, whereas IEX ligand functionality is fine-tuned using nontoxic-solution–based chemistry instead of toxic petrochemical solvents. That approach results in a covalently modified surface with robust, stable charge-bearing ligands that resists breakdown (up to 100 operational CIP cycles of 0.1 N NaOH every 10 cycles). This unique polymer composition allows the resin to maintain high porosity and efficient mass-transfer kinetics, matching the performance profiles of premium commercial media (agarose based) while remaining entirely compatible with natural biological carbon degradation pathways at its end of life.
The BioResin medium delivers competitive binding capacities and selectivity while withstanding industrial flow rates (150–400 cm/h) and CIP conditions. The material integrates into existing chromatography platforms and workflows, ensuring rapid adoption without extensive capital upgrades. Its compatibility with stirring tanks enables enhanced integration into large-scale processes at reduced costs when resolution between two similar proteins is not required. Crucially, BioResin technology also supports circular value chains by being manufactured from renewable feedstocks and by enabling DSP compatibility with global sustainability goals.
Validation Testing
To demonstrate the resin’s performance, Medium Well partnered with ARTES Biotechnology, a German contract development and manufacturing organization (CDMO) specializing in recombinant-protein production and full bioprocess DSP development, and the Protein Purification Laboratory at the Hebrew University of Jerusalem in Israel (HUJI).
Test Case 1 — Sweet Protein: The first validation case involved yeast-produced recombinant brazzein, a small peptide used as a sweetener. The peptide exhibits challenging charge properties and must be purified according to the stringent requirements typical of high-value food-grade ingredients.
Under conditions mirroring industrial chromatography operations, the BioResin medium matched the binding capacity, recovery yield, and impurity clearance of a leading commercial cation-exchange (CEX) resin. That result was achieved with a biodegradable medium at a fraction of the material cost, and with comparable stability across multiple reuse cycles in CIP conditions (Table 1).
BioResin Medium | Commercial IEX Resin | |
|---|---|---|
Cost | $100/L | $1300/L |
Binding capacity | 90 g/L | 100 g/L |
Estimated number of reuses | 100 | 100 |
Resin volume | 11.1 L | 10 L |
Investment in resin | $1111.11/kgP | $13,000/kgP |
Purification cost (Resin) | $11.1/kgP | $130/kgP |
CIP | $3.70 kgP | $3.70 kgP |
Utilities (water, energy, wastewater) | $3/kgP | $3/kgP |
Labor | $2/kgP | $2/kgP |
Total OpEx | $19.8/kgP | $138.7 kgP |
Total resin ratio | 0.6 | 0.6 |
Estimated equipment cost | $1/kgP | $1/kgP |
Total purification cost | $20.81/kgP | $139.70/kgP |
Table 1: Economic model comparison for total resin and purification costs for 1 kg of crude solution (kgP) containing the sweet protein brazzein; calculations were performed for laboratory and pilot scales. All costs are in US dollars. (CIP = cleaning in place, IEX = ion exchange, OpEx = operational expenditures)
Test Case 2 — Large Structural Protein: The second evaluation used a large vertebrate structural protein, representative of bulk food proteins requiring purification for advanced ingredient markets. Compared with a high-end chromatography resin, the BioResin medium delivered fractions of similarly high purity and exhibited similar stability. The BioResin product made it possible to work with a gentler pH value during chromatography while ensuring that the same level of separation performance was maintained as with a commercially available resin. The product also demonstrated consistent performance in capturing target molecules from complex streams, reducing the need for intermediate clarification steps and excessive buffer use (Table 2).
In both cases, the BioResin CEX medium matched or exceeded key performance metrics of alternative resins while maintaining biodegradability and sustainable manufacturing attributes sought by DSP practitioners.
BioResin | Commercial IEX Resin | |
|---|---|---|
Cost | $100/L | $1300L |
Binding capacity | 40 gr/L | 90 gr/L |
Estimated number of reuses | 75 | 75 |
Resin volume | 25 L | 11.1 L |
Investment in resin | $2500/kgP | $14,444.44/kgP |
Purification cost | $33.30/kgP | $192.60/kgP |
CIP | $3.70 /kgP | $3.70 /kgP |
Utilities (water, energy, wastewater) | $3/kgP | $3/kgP |
Labor | $2/kgP | $2/kgP |
Total OpEx | $42/kgP | $201.30 kgP |
Total resin ratio | 0.8 | 1 |
Estimated equipment cost | $1/kgP | $1/kgP |
Total purification cost | $43.03/kgP | $202.29/kgP |
Table 2: Economic model comparison for total resin and purification costs of 1 kg of a large structural protein; calculations were performed for laboratory and pilot scales. All costs are in US dollars. (CIP = cleaning in place, IEX = ion exchange, OpEx = operational expenditures)
Test Case 3 — Protein Enrichment in Potato Leaves: Ribulose-1,5-bisphosphate carboxylase/oxygenase (also called rubisco) is a ≈500-kDa hetero-oligomeric complex. It is the most abundant protein in potato-leaf extract. Purification is focused on separating small molecules (e.g., glycoalkaloids and phytochemicals), peptides, and protein aggregates from the bulk of the proteins, including rubisco.
The BioResin material can selectively bind rubisco and other proteins without interference of small molecules that are present in the extract. The resin can be cleaned in place and regenerated by a standard NaOH wash. Using IEX promotes both buffer exchange and rubisco separation in a single, fast procedure, preserving the complex oligomeric form of the protein, as was characterized by a size-exclusion chromatography (SEC) test (Figure 1).

Figure 1: Purification of rubisco from potato-leaf extract: (A) separation on a 1-mL column with BioResin media; (B) sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) with Coomassie staining of eluted pools; (C) analytical size-exclusion chromatography (SEC) of rubisco pool III using a high-end commercially available resin
Test Case 4 — Purification of Nanobody from Fermentation Broth: Purification of a 17-kDa protein was performed using Medium Well’s cation-exchange (CIEX) BioResin. Due to its varied structural conformations, the protein eluted at several peaks, all containing the active protein (Figure 2). This highlights the ability of the IEX resolution to distinguish between close molecular weight (MW) variants.
To evaluate the resolution limits of the CIEX BioResin matrix under complex biopharmaceutical conditions, purification runs were performed using unclarified fermentation broth containing a highly target-specific 17 kDa recombinant nanobody. Broth conditions represented a complex feedstock challenge, marked by high ionic conductivity, broad pH fluctuations, and a heavy background of host cell proteins (HCPs) and cellular debris.
The sample was loaded onto a 1 mL BioResin CIEX column equilibrated with a low-conductivity acetate buffer. Elution was executed via a step salt gradient (0.1–0.5 N NaCl). The target nanobody consistently eluted across a distinct multi-peak profile rather than a single broad pool. Analytical scale-up and size-exclusion chromatography (SEC) verification confirmed that each distinct peak contained fully functional, biologically active structural conformations and close molecular weight variants of the target molecule. This high-resolution separation demonstrates that the charge-density distribution on the BioResin surface can efficiently discriminate between subtle surface-charge anomalies and native conformations within complex protein populations. The matrix effectively isolated the active target from the crude fermentation stream in a single, fast step, reducing the reliance on precolumn secondary clarification loops.

Figure 2: Protein purification chromatograms: (A) separation on a 1-mL column with BioResin media; (B) sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) with Coomassie staining of eluted pool; (C) analytical size-exclusion chromatography (SEC) of eluted protein pool III using a high-end commercially available resin
A large-volume pilot of 90 L was also conducted in July 2026 at CDMO pilot facility using the same recombinant nanobody. The process combined loading of filtered fermentation broth containing nanobody (350 g) on 10-liter Medium Well’s CIEX BioResin in a stirred tank for one hour, followed by pumping the resin into a gravity column for wash and elution (Figure 3). The process was operationally straightforward and scaled up from 0.5 L with minor changes.
The results were as follows: 275 g of high-purity nanobody at 80% recovery within two column volumes (CV), 310 g at 88% recovery within five CV, and 95% recovery within 10 CV. The functionality of the nanobody was retained. Although the process was not yet optimized, IEX performed better than filtration in many critical issues of scale up. For example, the duration of IEX was three hours, compared with reasonable membrane surface of 1 m2 in five hours. The functionality and recovery of the nanobody were significantly improved.

Figure 3: Illustration of the nanobody purification process with BioResin product, combining a stirring tank and gravity column; MWCO = molecular weight cut-off.
Test Case 5 — Comparison for Lactoferrin: A comparative techno-economic assessment of recombinant lactoferrin purification was performed by Intelligen using the SuperPro Designer bioprocess-simulation platform. The modeling compared the BioResin medium against a commercially available IEX resin under equivalent process assumptions, including identical bed height, buffer strategy, and reuse cycles.
The analysis demonstrated that BioResin achieved comparable process performance while substantially reducing DSP costs. Under modeled conditions prior to specific process optimization, unit production costs were estimated at ≈$400/kg of lactoferrin using the BioResin medium and ≈$1000/kg using the alternative resin. The media achieved similar purification performance at the same production scale, and estimated production costs remained high; however, the simulations revealed a major difference in process cost structure. Consumables represented ≈65% of total production cost in the industry-standard CEX process compared with only ≈14% when using the BioResin resin (Figure 4).

Figure 4: Comparison of annual operational expenditures (OpEx) for recombinant lactoferrin purification with a commercial ion-exchange (IEX) resin (top) and BioResin (bottom); QA = quality assurance, QC = quality control
Importantly, the modeling highlights that DSP remains a major economic bottleneck in precision-fermentation–derived protein manufacturing overall. However, the results suggest that alternative chromatography materials such as the BioResin medium could significantly shift the economic feasibility window of large-scale biomanufacturing by reducing dependence on expensive chromatography consumables while maintaining industrially relevant purification performance.
The simulation further emphasizes the importance of integrated process optimization. Sensitivity analyses indicate that parameters such as fermentation titer, recovery yield, resin lifetime, and process throughput can substantially influence final economics, suggesting that the impact of low-cost chromatography media may become even more pronounced under optimized commercial-scale conditions.
Those findings demonstrate the value of combining advanced techno-economic modeling with novel DSP materials to identify scalable and economically viable purification strategies for next-generation food and industrial biotechnology applications.
Bridging Cost and Purity
The rapid expansion of precision fermentation and bio-based manufacturing is placing unprecedented pressure on DSP technologies to deliver not only high purity, but also industrial scalability, economic feasibility, and sustainability. The BioResin medium represents a new generation of chromatography materials designed specifically for these emerging requirements.
Across multiple validation cases as presented here, the BioResin product demonstrated industrially relevant purification performance while substantially reducing material-related process costs compared with conventional IEX media. Combined with biodegradability, compatibility with existing DSP infrastructure, and promising techno-economic modeling results, the BioResin medium illustrates how next-generation purification materials may help reshape the economics and sustainability profile of large-scale biomanufacturing. Although DSP remains a major bottleneck for the industry overall, this work highlights the potential of integrated material innovation and process optimization to unlock commercially viable pathways for the future of food, industrial biotechnology, and sustainable protein production.
References
1 Alawiyah AL. Integrated Downstream Separation in Bioprocessing: Enhancing Yield, Purity, and Sustainability through Membrane and Adsorption Technologies. Catalyx J. Proc. Chem. Technol. 2(3) 2025: 147–159; https://doi.org/10.61978/catalyx.v2i3.1336.
2 Straathof AJJ. The Proportion of Downstream Costs in Fermentative Production Processes. Comprehensive Biotechnology. Moo-Young M, Ed. Elsevier: Amsterdam, the Netherlands, 2011.
3 Buyel JF. Developing Downstream Processes for the Purification of Recombinant Proteins and Small Molecules from Nicotiana benthamiana Biomass. Plant Biotechnol. J. 24(1) 2026: 66–88; https://doi.org/10.1111/pbi.70231.
Nir Berdugo, PhD, is cofounder and chief technology officer of Medium Well. Corresponding author Shelly Lotan ([email protected]) is cofounder and chief executive officer of Medium Well. Stefan Rasche, PhD, is Head of Department Precision Fermentation at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME. Hadar Amartely, PhD, is head of the protein purification and characterization facility at the Hebrew University of Jerusalem. Michael Piontek, PhD, is managing director, and Michael Weniger is head of process development, both at ARTES Biotechnology GmbH. Rafael da Gama Ferreira, PhD, is senior process design engineer, and Nikiforos Misailidis, PhD, is director of consulting and training services, both at Intelligen.
Please cite this article as: Berdugo N, et al. Enabling Sustainable and Cost-Effective Downstream Processing for the Next Generation of Industrial Biotechnology. BioProcess Int. 24(11) 2026: 241107.
来源:BioProcess International · 工艺与质量 · bioprocessintl.com